Browsing by Author Mileshkin, Linda

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2016Continuing variation and barriers to nurse-led vaginal dilator education for women with gynaecological cancer receiving radiotherapyJuraskova, Ilona; Aranda, Sanchia; Bergin, Rebecca; Bernshaw, David; Hocking, Alison; Kabel, Donna; Mileshkin, Linda; Robinson, Taryn; Schofield, Penelope; PsychologyContinuing variation and barriers to nurse-led vaginal dilator education for women with gynaecological cancer receiving radiotherapy, European Journal of Oncology Nursing, vol.24, N/A, 2016,pp 20-21
2016Developing an evidence-based, nurse-led psychoeducational intervention with peer support in gynecologic oncologyJuraskova, Ilona; Aranda, Sanchia; Bergin, Rebecca; Bernshaw, David; Grogan, Suzi; Hocking, Alison; Krishnasamy, Meinir; Mileshkin, Linda; Penberthy, Sylvia; Schofield, Penelope; PsychologyDeveloping an evidence-based, nurse-led psychoeducational intervention with peer support in gynecologic oncology, Cancer Nursing, vol.39, 2, 2016,pp E19-E30
2015Geriatric assessment of older patients with cancer in Australia-A multicentre auditMarx, Gavin; Tattersall, Martin; Della Fiorentina, Stephen; Dunlop, Tracey; et al, Various; Hovey, Elizabeth; Joshi, Sachin; Lakhanpal, Roopa; Liew, Sem; Mileshkin, Linda; Venkateswaran, Lakshmi; Yip, Desmond; Yoong, Jaclyn; Medicine; Central Clinical School: MedicineGeriatric assessment of older patients with cancer in Australia-A multicentre audit, Journal of Geriatric Oncology, vol.6, 3, 2015,pp 185-193
2014Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)deFazio, Anna; Au-Yeung, George; Bressel, Mathias; Feredaye, Sian; Mileshkin, Linda; Webb, Penelope M.; Western Clinical School: Westmead Millennium InstituteImpact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS), Gynecologic Oncology, vol.133, 1, 2014,pp 16-22
2013A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trialJuraskova, Ilona; White, Kathryn; Aranda, Sanchia; Bergin, Rebecca; Bernshaw, David; Gough, Karla; Krishnasamy, Meinir; Mileshkin, Linda; Penberthy, Sylvia; Schofield, Penelope; Psychology; Faculty of Nursing & MidwiferyA nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trial, Trials, vol.14, 1, 2013,pp 1-11
2017Paragon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancerBeale, Philip; deFazio, Anna; Friedlander, Michael; Mapagu, Cristina; Martyn, Julie; Mileshkin, Linda; O'Connell, Rachel; Sjoquist, Katrin; Bonaventura, Anthony; Goh, J; Grant, Peter; Hadley, Alison; McNally, Orla; Scurry, James P; Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Childrens Hospital Westmead: Paediatrics & Child Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreParagon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancer, International Journal of Gynecological Cancer, vol.27, 5, 2017,pp 900-906
2016Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trialBlinman, Prunella; Kolodziej, Ilka; O'Connell, Rachel; Stockler, Martin; Wain, Gerard; Brooks, Susan; Capp, A.; et al, Various; Goss, Geraldine; Johnson, Carol; Khaw, Pearly; Mileshkin, Linda; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & GynaecologyPatients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial, British Journal of Cancer, vol.115, 10, 2016,pp 1179-1185
2016Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trialBlinman, Prunella; Kolodziej, Ilka; O'Connell, Rachel; Stockler, Martin; Wain, Gerard; Brooks, Susan; Capp, A.; et al, Various; Goss, Geraldine; Johnson, Carol; Khaw, Pearly; Mileshkin, Linda; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Obstetrics & GynaecologyPatients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: An ANZGOG substudy of the PORTEC-3 intergroup randomised trial, British Journal of Cancer, vol.115, 10, 2016,pp 1179-1185
2016PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancerLindemann, Kristina; Martyn, Julie; Willson, Melina; Mileshkin, Linda; Roncolato, Felicia; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer, Cochrane Database of Systematic Reviews, vol.2016, 4, 2016,pp N/A-N/A
2016Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trialDo, Viet; Foo, Kerwyn; Holloway, Lois; Bailey, Michael; Creutzberg, Carien; Jameson, Michael; Khaw, Pearly; McNamara, Jo; Metcalfe, Peter; Mileshkin, Linda; Nepean Clinical School: Medicine; Central Clinical School: Medicine; PhysicsResults of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trial, Journal of Medical Imaging and Radiation Oncology, vol.60, 4, 2016,pp 554-559
2015Weighing up the benefits and harms of a new anti-cancer drug - a survey of Australian oncologistsChim, Lesley; Salkeld, Glenn; Stockler, Martin; Mileshkin, Linda; School of Public Health: Public Health; School of Public Health: Public Health; NH&MRC Clinical Trials CentreWeighing up the benefits and harms of a new anti-cancer drug - a survey of Australian oncologists, Internal Medicine Journal, vol.45, 8, 2015,pp 834-842